Meeting
Abstract Number: 317
Hospital Medicine 2020, Virtual Competition
Background: Myelofibrosis is a chronic myeloproliferative neoplasm characterized by progressive bone marrow fibrosis and extramedullary hematopoiesis leading to splenomegaly. Progressive splenomegaly is common in advanced myelofibrosis, and spleen volume is a predictor of survival. The oral selective small-molecule JAK 1/2 inhibitor ruxolitinib is used for symptomatic management of intermediate-2 and high-risk myelofibrosis, and leads to […]
Abstract Number: 611
SHM Converge 2021
Case Presentation: A 35-year-old Caucasian male patient presented to our clinic complaining of fatigue, proximal muscle weakness, and pain. Twelve years ago, he was diagnosed with acute myeloid leukaemia, and due to poor prognostic factors, he underwent allogeneic HSCT from his sister, an HLA full-matched sibling donor. His past medical history is significant for chronic […]
Abstract Number: 800
SHM Converge 2024
Case Presentation: A 53-year-old male, post-allogeneic hematopoietic stem cell transplant (HSCT) for relapsed acute myeloid leukemia (AML) presented to an outside hospital with high fevers, frontal lobe headaches, and blood-tinged sinus drainage, two weeks after completing chemotherapy. Days later, the patient was transferred to our hospital for advanced care, reporting continued fevers (up to 38.6oC), […]